Chloroquine for Reducing Immune Activation in HIV- Infected Individuals

NCT00819390 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

NETWORK

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Chloroquine
DRUG: Placebo

Sponsor

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

Collaborators

[object Object]